Phase 2 Randomized Trial Supports Roflumilast as a Potential Treatment for Seborrheic Dermatitis
1. Erythema, scaling, and itching caused by seborrheic dermatitis (SD) significantly decreased with roflumilast treatment. 2. Roflumilast treated for SD ...